None listed
Conditions
Interventions
Dietary Supplement :
- Lythrum salicaria extract 1,350mg/day(500mg/day as Lythrum salicaria)
- oral intake with water at breakfast, lunch, dinner
- intake period: total 84 days(12 weeks)
- Lactose,
Sponsors
Sangji University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. A person who consented to participate in this study and voluntarily signed a written consent form 2. Adult men and women between the ages of 19 and 75 3. A person with a body mass index(BMI) of 23 to 30 kg/m2
Exclusion criteria
Exclusion criteria: 1. Subjects with severe cerebrovascular disease(cerebral infarction, cerebral hemorrhage, etc.), heart disease(angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), or malignant tumor within the last 6 months 2. Patients with uncontrolled hypertension (blood pressure of 160/100mmHg or higher, measurement standard after subject resting for 10 minutes) 3. Diabetic patients with poor blood sugar control (fasting blood sugar of 160mg/dl or higher) 4. Those who are being treated for hypothyroidism or hyperthyroidism 5. A person whose creatinine measurement value is more than twice the upper limit of normal of the research institution 6. A person whose AST (GOT) or ALT (GPT) measurement value is more than 3 times the upper limit of normal of the research institution 7. Those who complain of severe gastrointestinal symptoms such as heartburn and indigestion (lactose intolerance) 8. A person who has been taking drugs that affect weight within the past month 9. Those who have participated in a commercial obesity program within the last 3 months 10. Those who have participated or plan to participate in other clinical trials within the last month 11. Alcohol Abuse 12. Non-smoking within 3 months 13. Those who are pregnant/lactating or plan to become pregnant during the human application test period 14. A person who has an allergic reaction to component foods 15. A person who is judged to be unsuitable by the tester for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| body fat mass(kg) through DEXA(Dual Energy X-Ray Absorptiometry) | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index(BMI);body weight(BWT);Waist to Hip Ratio(WHR);Body fat percentage (%), lean body mass (kg) through DEXA;Lipids(total cholesterol, Tryglyceride, HDL-C, calculated LDL-C);Free Fatty Acid(FFA);hs-CRP;Adiponectin;Leptin | — |
Countries
Korea, Republic of
Contacts
Public ContactHyejin Park
Pusan National University Korean Medicine Hospital
Outcome results
None listed